L2L L2L Microarray Analysis Tool

Results for P02CA.profile.u50

Results summary View all lists in L2L MDB View all genes in P02CA.profile.u50
List Name Description Total
probes
Expected
matches
Actual
matches
Fold
Enrichment
Binomial
p-value
uvb_nhek3_c3 Regulated by UV-B light in normal human epidermal keratinocytes, cluster 3 37 0.09 4 43.73 2.31e-06
tpa_sens_early_up Upregulated by TPA at two consecutive timepoints between 15min-3hrs in sensitive HL-60 cells 97 0.24 5 20.85 4.92e-06
heatshock_hela_4hr_up Up-regulated at 4 hours following 1.5 hr 43degC heat shock of HeLa cells compared to untreated controls (> 1.5-fold, FDR < 0.05). 675 1.67 10 5.99 9.75e-06
tpa_sens_middle_up Upregulated by TPA at two consecutive timepoints between 2-24hrs in sensitive HL-60 cells 114 0.28 5 17.74 1.08e-05
dac_cgi_bladder_up Upregulated by DAC treatment in T24 bladder carcinoma cells, with 5' CpG island 26 0.06 3 46.68 3.76e-05
brca_er_neg Genes whose expression is consistently negatively correlated with estrogen receptor status in breast cancer - higher expression is associated with ER-negative tumors 1519 3.75 14 3.73 3.82e-05
uvc_high_all_up Up-regulated at any timepoint following treatment of WS1 human skin fibroblasts with UVC at a high dose (50 J/m^2) (clusters b1-b4) 34 0.08 3 35.69 8.53e-05
alk1_hmvec_2hr_up Up-regulated 2 hr following constitutive activation of TGFbeta receptor ALK1, which activates the Smad1/5 pathway, in human microvessel endothelial cells (HMVEC). 593 1.47 8 5.46 1.41e-04
alk1_hmvec_4hr_up Up-regulated 4 hr following constitutive activation of TGFbeta receptor ALK1, which activates the Smad1/5 pathway, in human microvessel endothelial cells (HMVEC). 593 1.47 8 5.46 1.41e-04
dex_keratinocyte_1hr_up Up-regulated in primary human keratinocytes at 1 hour following treatment with 0.1 microM dexamethasone 8 0.02 2 101.14 1.69e-04
dac_panc_up Upregulated by DAC treatment in at least one of four pancreatic cancer cell lines, but not in normal (HPDE) cells 654 1.62 8 4.95 2.71e-04
aged_rhesus_dn Downregulated in the vastus lateralis muscle of aged vs. young adult rhesus monkeys 232 0.57 5 8.72 3.11e-04
dac_bladder_up Upregulated by DAC treatment in T24 bladder carcinoma cells 60 0.15 3 20.23 4.65e-04
igfr_vs_ir_up Up-regulated following stimulation of chimeric TrkC/IGFR in NIH3T3 cells, compared to stimulation of TrkC/IR 13 0.03 2 62.24 4.68e-04
hdaci_colon_tsa2hrs_up Upregulated by TSA at 2 hrs in SW260 colon carcinoma cells 61 0.15 3 19.90 4.88e-04
tnfa_nfkb_ind_up Up-regulated at any timepoint following TNFa treatment, independent of NFkB function 14 0.03 2 57.79 5.45e-04
bay_pbmc_24hr_dn Down-regulated at 24 hr following treatment of peripheral blood mononuclear cells (PBMC) with BAY 50-4798, an IL-2 receptor agonist. 268 0.66 5 7.55 5.98e-04
dsrna_up Upregulated by dsRNA (polyI:C) in IFN-null GRE cells 68 0.17 3 17.85 6.71e-04
hypoxia_review Genes known to be induced by hypoxia 160 0.40 4 10.11 7.22e-04
senescence_hff_dn Down-regulated in primary human foreskin fibroblasts at replicative senescence (passage 26) compared to active replication (passage 8). 299 0.74 5 6.76 9.75e-04
hdaci_colon_tsabut_up Upregulated by both butyrate and TSA at any timepoint up to 48 hrs in SW260 colon carcinoma cells 79 0.20 3 15.36 1.04e-03
uv-cmv_unique_hcmv_6hrs_up Up-regulated in fibroblasts at 6 hours following infection with UV-inactivated CMV, but not untreated CMV 194 0.48 4 8.34 1.47e-03
reovirus_hek293_up Up-regulated at any timepoint up to 24 hours following infection of HEK293 cells with reovirus strain T3Abney 491 1.21 6 4.94 1.56e-03
et743_resist_dn Down-regulated in two Et-743-resistant cell lines (chondrosarcoma and ovarian carcinoma) compared to sensitive parental lines 95 0.23 3 12.77 1.76e-03
tpa_sens_late_up Upregulated by TPA at two consecutive timepoints between 12-48 hrs in sensitive HL-60 cells 95 0.23 3 12.77 1.76e-03
ifnalpha_resist_dn Down-regulated in mycosis fungoides (cutaneous T-cell lymphoma) T-cells resistant to IFN-alpha, compared to sensitive parent cell line 25 0.06 2 32.36 1.77e-03
middleage_up Upregulated in fibroblasts from middle-age individuals, compared to young 25 0.06 2 32.36 1.77e-03
tnfa_nfkb_dep_up Up-regulated at any timepoint following TNFa treatment, only with functional NFkB 26 0.06 2 31.12 1.91e-03
hbx_nl_dn Downregulated by expression of Hepatitis B virus HBx protein in normal hepatocytes (Hhep) (Fig. 3B+C) 27 0.07 2 29.97 2.06e-03
egf_hdmec_up Up-regulated in human dermal (foreskin) microvascular endothelial cells that were stimulated to proliferate with prolonged EGF treatment, versus non-stimulated quiescent controls. 105 0.26 3 11.56 2.35e-03
cmv-uv_hcmv_6hrs_up Up-regulated in fibroblasts at 6 hours following infection with UV-inactivated human cytomegalovirus 226 0.56 4 7.16 2.56e-03
mkk6ee_up Upregulated by expression of constitutively active MKK6 31 0.08 2 26.10 2.71e-03
cpr_null-low_liver_up Up-regulated in mouse liver tissue from mice in which NADPH-cytochrome P450 reductase (CPR) was specifically deleted in the liver by cre-lox recombination, versus mice with low expression of CPR 34 0.08 2 23.80 3.25e-03
gamma_unique_fibro_dn Down-regulated at any timepoint by treatment of human fibroblasts with gamma radiation, but not by UV lght or 4-NQO 120 0.30 3 10.11 3.42e-03
as3_fibro_c4 Downregulated early by sodium arsenite in fibroblasts (Cluster 4) 35 0.09 2 23.12 3.44e-03
dex_keratinocyte_4hr_up Up-regulated in primary human keratinocytes at 4 hours following treatment with 0.1 microM dexamethasone 35 0.09 2 23.12 3.44e-03
hdaci_colon_tsa_up Upregulated by TSA at any timepoint up to 48 hrs in SW260 colon carcinoma cells 122 0.30 3 9.95 3.58e-03
caries_pulp_up Up-regulated in pulpal tissue from extracted carious teeth (cavities), compared to tissue from extracted healthy teeth 410 1.01 5 4.93 3.81e-03
ros_mouse_aorta_dn Down-regulated in mouse aorta by chronic treatment with PPARgamma agonist rosiglitazone 127 0.31 3 9.56 4.01e-03
hdaci_colon_sul12hrs_up Upregulated by sulindac at 12 hrs in SW260 colon carcinoma cells 40 0.10 2 20.23 4.48e-03
csb_robust_up Up-regulated robustly by stable expression of wt CSB in hTERT-immortalized CS1AN CSB-null fibroblasts vs. eGFP-expressing controls (9 of 9 pairwise comparisons). 140 0.35 3 8.67 5.25e-03
hbx_hcc_dn Downregulated by expression of Hepatitis B virus HBx protein in SK-Hep-1 hepatocellular carcinoma cells (Fig. 3B+D) 47 0.12 2 17.21 6.14e-03
hdaci_colon_but16hrs_up Upregulated by butyrate at 16 hrs in SW260 colon carcinoma cells 47 0.12 2 17.21 6.14e-03
hg_progeria_dn Downregulated in fibroblasts from patients with Hutchinson-Gilford progeria, compared to normal young individuals 48 0.12 2 16.86 6.39e-03
p53_brca1_up Upregulated by expression of p53 in p53-null, brca1-null MEFs; most genes are further upregulated by simultaneous expression of BRCA1 49 0.12 2 16.51 6.65e-03
brg1_h1299_up Up-regulated by transient expression of BRG1 in H1299 lung cancer cells with mutant, inactive BRG1 50 0.12 2 16.18 6.92e-03
tsa_hepatoma_cancer_dn Cancer-related genes down-regulated in any of four human hepatoma cell lines following 24-hour treatment with 200ng/mL of trichostatin A 51 0.13 2 15.86 7.19e-03
irs1_ko_adip_up Up-regulated in brown preadipocytes from Irs1-knockout mice, which display severe defects in adipocyte differentiation, versus wild-type controls 159 0.39 3 7.63 7.45e-03
hdaci_colon_but12hrs_up Upregulated by butyrate at 12 hrs in SW260 colon carcinoma cells 54 0.13 2 14.98 8.03e-03
hypoxia_rcc_up Upregulated by hypoxia in VHL-rescued renal carcinoma cells (Fig. 3f+g) 170 0.42 3 7.14 8.94e-03
il2_pbmc_4hr_up Up-regulated at 4 hr following treatment of peripheral blood mononuclear cells (PBMC) with recombinant IL-2. 510 1.26 5 3.97 9.34e-03
as3_fibro_dn Downregulated by sodium arsenite in fibroblasts (Clusters 4, 5, and 6) 59 0.15 2 13.71 9.52e-03
csb_reliable_up Up-regulated reliably by stable expression of wt CSB in hTERT-immortalized CS1AN CSB-null fibroblasts vs. eGFP-expressing controls (7 of 9 pairwise comparisons). 513 1.27 5 3.94 9.56e-03

Raw data (tab-delimited .txt)